Cargando…
USP17 is required for trafficking and oncogenic signaling of mutant EGFR in NSCLC cells
BACKGROUND: The deubiquitinase USP17 is overexpressed in NSCLC and has been shown to be required for the growth and motility of EGFR wild-type (WT) NSCLC cells. USP17 is also required for clathrin-mediated endocytosis of EGFR. Here, we examine the impact of USP17 depletion on the growth, as well as...
Autores principales: | McCann, Aidan P., Smyth, Peter, Cogo, Francesco, McDaid, William J., Jiang, Lai, Lin, Jia, Evergren, Emma, Burden, Roberta E., Van Schaeybroeck, Sandra, Scott, Christopher J., Burrows, James F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6225634/ https://www.ncbi.nlm.nih.gov/pubmed/30409180 http://dx.doi.org/10.1186/s12964-018-0291-5 |
Ejemplares similares
-
USP17 is required for peripheral trafficking of lysosomes
por: Lin, Jia, et al.
Publicado: (2022) -
USP17 is required for clathrin mediated endocytosis of epidermal growth factor receptor
por: Jaworski, Jakub, et al.
Publicado: (2014) -
Aberrant trafficking of NSCLC-associated EGFR mutants through the endocytic recycling pathway promotes interaction with Src(@)
por: Chung, Byung Min, et al.
Publicado: (2009) -
A Novel Indication for Panobinostat as a Senolytic Drug in NSCLC and HNSCC
por: Samaraweera, Leleesha, et al.
Publicado: (2017) -
Hope and Challenges: Immunotherapy in EGFR-Mutant NSCLC Patients
por: Yan, Dan
Publicado: (2023)